Macquarie Group’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$75.4M Buy
5,097,482
+300,168
+6% +$4.44M 0.09% 303
2025
Q1
$86M Buy
4,797,314
+537,757
+13% +$9.64M 0.11% 268
2024
Q4
$74.2M Sell
4,259,557
-13,357
-0.3% -$233K 0.09% 311
2024
Q3
$59.8M Sell
4,272,914
-94,916
-2% -$1.33M 0.06% 398
2024
Q2
$35.9M Sell
4,367,830
-245,229
-5% -$2.02M 0.04% 506
2024
Q1
$35.6M Sell
4,613,059
-133,717
-3% -$1.03M 0.04% 532
2023
Q4
$42.7M Buy
4,746,776
+74,917
+2% +$674K 0.05% 479
2023
Q3
$41.8M Buy
4,671,859
+718,745
+18% +$6.43M 0.05% 456
2023
Q2
$60.7M Buy
3,953,114
+308,427
+8% +$4.74M 0.07% 363
2023
Q1
$82M Buy
3,644,687
+88,575
+2% +$1.99M 0.1% 279
2022
Q4
$74.8M Buy
3,556,112
+245,856
+7% +$5.17M 0.09% 317
2022
Q3
$81.6M Sell
3,310,256
-358,423
-10% -$8.83M 0.1% 279
2022
Q2
$88.9M Buy
3,668,679
+55,778
+2% +$1.35M 0.1% 269
2022
Q1
$93.1K Sell
3,612,901
-154,991
-4% -$3.99K 0.07% 313
2021
Q4
$117M Sell
3,767,892
-183,949
-5% -$5.71M 0.1% 275
2021
Q3
$95.8M Buy
3,951,841
+39,428
+1% +$956K 0.08% 312
2021
Q2
$57.1M Buy
3,912,413
+1,174,860
+43% +$17.1M 0.05% 496
2021
Q1
$68.4M Sell
2,737,553
-26,369
-1% -$658K 0.1% 260
2020
Q4
$75.3M Sell
2,763,922
-441,682
-14% -$12M 0.11% 207
2020
Q3
$59.2M Sell
3,205,604
-303,324
-9% -$5.6M 0.1% 215
2020
Q2
$71.6M Buy
3,508,928
+150,927
+4% +$3.08M 0.12% 177
2020
Q1
$49M Buy
3,358,001
+280,812
+9% +$4.1M 0.1% 214
2019
Q4
$43.7M Buy
3,077,189
+388,488
+14% +$5.52M 0.06% 330
2019
Q3
$31.2M Buy
2,688,701
+91,777
+4% +$1.06M 0.05% 360
2019
Q2
$52.2M Buy
2,596,924
+97,848
+4% +$1.97M 0.09% 254
2019
Q1
$56.6M Buy
2,499,076
+233,152
+10% +$5.28M 0.1% 218
2018
Q4
$51.3M Buy
2,265,924
+339,588
+18% +$7.68M 0.1% 209
2018
Q3
$55.3M Buy
1,926,336
+308,718
+19% +$8.87M 0.09% 236
2018
Q2
$44.1M Buy
1,617,618
+177,604
+12% +$4.84M 0.08% 276
2018
Q1
$32.2M Buy
1,440,014
+99,365
+7% +$2.22M 0.06% 349
2017
Q4
$28.2M Sell
1,340,649
-118,569
-8% -$2.5M 0.05% 389
2017
Q3
$36.3M Buy
1,459,218
+270,399
+23% +$6.73M 0.07% 299
2017
Q2
$23.1M Buy
1,188,819
+172,389
+17% +$3.34M 0.04% 415
2017
Q1
$18.8M Buy
1,016,430
+137,149
+16% +$2.53M 0.03% 472
2016
Q4
$16.6M Buy
879,281
+61,549
+8% +$1.17M 0.03% 491
2016
Q3
$18.3M Sell
817,732
-1,040,900
-56% -$23.3M 0.04% 441
2016
Q2
$33.1M Buy
1,858,632
+1,337,597
+257% +$23.8M 0.03% 430
2016
Q1
$7.12M Buy
521,035
+66,832
+15% +$913K 0.01% 629
2015
Q4
$8.76M Buy
454,203
+158,360
+54% +$3.05M 0.02% 576
2015
Q3
$5.99M Buy
295,843
+85,040
+40% +$1.72M 0.01% 671
2015
Q2
$6.99M Buy
+210,803
New +$6.99M 0.01% 654